カテゴリ： 世界, 医療/バイオ, QYResearch

医療用ソフトカプセルの世界市場2023年：ゼラチンタイプ、ノンアニマルタイプ

■ 英語タイトル：Global Medical Soft Capsules Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8813）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8813
■ 発行日：2023年3月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：116
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥429,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥643,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥858,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[医療用ソフトカプセルの世界市場2023年：ゼラチンタイプ、ノンアニマルタイプ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は医療用ソフトカプセルのグローバル市場について調査・分析し、世界の医療用ソフトカプセル市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ゼラチンタイプ、ノンアニマルタイプ）、用途別セグメント分析（病院、クリニック、医療機関、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、GSK、Aenova、Catalent、Boehringer Ingelheim、Nature’s Bounty、Patheon (Thermo Fisher Scientific)、Procaps、AstraZeneca、Aland、Vertex、Novartis、EuroCaps、Strides Pharma Science、Captek、Soft Gel Technologies、NextPharma (from Lonza)、Roche、Amway、Sirio Pharma Co., Ltd、Weihai Baihe Biology Technological Co., Ltd、Douglas、Shineway Pharma、Tsinghua Unigroup、Donghai Pharm、Yi Chao、Yuwang Groupなどが含まれています。医療用ソフトカプセルのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、医療用ソフトカプセル市場規模を算出する際に考慮しました。

・医療用ソフトカプセル市場の概要
- 製品の定義
- 医療用ソフトカプセルの種類別セグメント
- 世界の医療用ソフトカプセル市場規模：タイプ別分析（ゼラチンタイプ、ノンアニマルタイプ）
- 医療用ソフトカプセルの用途別セグメント
- 世界の医療用ソフトカプセル市場規模：用途別分析（病院、クリニック、医療機関、その他）
- 世界の医療用ソフトカプセル市場規模予測（2018年-2029年）
- 医療用ソフトカプセルの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 医療用ソフトカプセル市場の競争状況およびトレンド

・医療用ソフトカプセルの地域別市場規模
- 北米の医療用ソフトカプセル市場規模（2018年-2029年）
- 米国の医療用ソフトカプセル市場規模（2018年-2029年）
- ヨーロッパの医療用ソフトカプセル市場規模（2018年-2029年）
- アジア太平洋の医療用ソフトカプセル市場規模（2018年-2029年）
- 中国の医療用ソフトカプセル市場規模（2018年-2029年）
- 日本の医療用ソフトカプセル市場規模（2018年-2029年）
- 韓国の医療用ソフトカプセル市場規模（2018年-2029年）
- インドの医療用ソフトカプセル市場規模（2018年-2029年）
- オーストラリアの医療用ソフトカプセル市場規模（2018年-2029年）
- 中南米の医療用ソフトカプセル市場規模（2018年-2029年）
- 中東・アフリカの医療用ソフトカプセル市場規模（2018年-2029年）

・種類別セグメント：ゼラチンタイプ、ノンアニマルタイプ
- 世界の医療用ソフトカプセルのタイプ別販売量（2018年-2023年）
- 世界の医療用ソフトカプセルのタイプ別売上（2018年-2023年）
- 世界の医療用ソフトカプセルのタイプ別価格

・用途別セグメント：病院、クリニック、医療機関、その他
- 世界の医療用ソフトカプセルの用途別販売量（2018年-2023年）
- 世界の医療用ソフトカプセルの用途別売上（2018年-2023年）
- 世界の医療用ソフトカプセルの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
GSK、Aenova、Catalent、Boehringer Ingelheim、Nature’s Bounty、Patheon (Thermo Fisher Scientific)、Procaps、AstraZeneca、Aland、Vertex、Novartis、EuroCaps、Strides Pharma Science、Captek、Soft Gel Technologies、NextPharma (from Lonza)、Roche、Amway、Sirio Pharma Co., Ltd、Weihai Baihe Biology Technological Co., Ltd、Douglas、Shineway Pharma、Tsinghua Unigroup、Donghai Pharm、Yi Chao、Yuwang Group

・産業チェーンと販売チャネルの分析
- 医療用ソフトカプセル産業チェーン分析
- 医療用ソフトカプセルの主要原材料
- 医療用ソフトカプセルの販売チャネル
- 医療用ソフトカプセルのディストリビューター
- 医療用ソフトカプセルの主要顧客

・医療用ソフトカプセル市場ダイナミクス
- 医療用ソフトカプセルの業界動向
- 医療用ソフトカプセル市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Medical Soft Capsules market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Medical Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Medical Soft Capsules is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Medical Soft Capsules include GSK, Aenova, Catalent, Boehringer Ingelheim, Nature’s Bounty, Patheon (Thermo Fisher Scientific), Procaps, AstraZeneca and Aland, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Soft Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Soft Capsules.
The Medical Soft Capsules market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Soft Capsules market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Soft Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
GSK
Aenova
Catalent
Boehringer Ingelheim
Nature’s Bounty
Patheon (Thermo Fisher Scientific)
Procaps
AstraZeneca
Aland
Vertex
Novartis
EuroCaps
Strides Pharma Science
Captek
Soft Gel Technologies
NextPharma (from Lonza)
Roche
Amway
Sirio Pharma Co., Ltd
Weihai Baihe Biology Technological Co., Ltd
Douglas
Shineway Pharma
Tsinghua Unigroup
Donghai Pharm
Yi Chao
Yuwang Group
Segment by Type
Gelatin Type
Non-Animal Type
Segment by Application
Hospital
Clinic
Medical Institutions
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Soft Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Medical Soft Capsules Market Overview
1.1 Product Overview and Scope of Medical Soft Capsules
1.2 Medical Soft Capsules Segment by Type
1.2.1 Global Medical Soft Capsules Market Value Comparison by Type (2023-2029)
1.2.2 Gelatin Type
1.2.3 Non-Animal Type
1.3 Medical Soft Capsules Segment by Application
1.3.1 Global Medical Soft Capsules Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Institutions
1.3.5 Others
1.4 Global Medical Soft Capsules Market Size Estimates and Forecasts
1.4.1 Global Medical Soft Capsules Revenue 2018-2029
1.4.2 Global Medical Soft Capsules Sales 2018-2029
1.4.3 Global Medical Soft Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Medical Soft Capsules Market Competition by Manufacturers
2.1 Global Medical Soft Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Medical Soft Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Medical Soft Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Medical Soft Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Medical Soft Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Soft Capsules, Product Type & Application
2.7 Medical Soft Capsules Market Competitive Situation and Trends
2.7.1 Medical Soft Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Soft Capsules Players Market Share by Revenue
2.7.3 Global Medical Soft Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Soft Capsules Retrospective Market Scenario by Region
3.1 Global Medical Soft Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Medical Soft Capsules Global Medical Soft Capsules Sales by Region: 2018-2029
3.2.1 Global Medical Soft Capsules Sales by Region: 2018-2023
3.2.2 Global Medical Soft Capsules Sales by Region: 2024-2029
3.3 Global Medical Soft Capsules Global Medical Soft Capsules Revenue by Region: 2018-2029
3.3.1 Global Medical Soft Capsules Revenue by Region: 2018-2023
3.3.2 Global Medical Soft Capsules Revenue by Region: 2024-2029
3.4 North America Medical Soft Capsules Market Facts & Figures by Country
3.4.1 North America Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Medical Soft Capsules Sales by Country (2018-2029)
3.4.3 North America Medical Soft Capsules Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Medical Soft Capsules Market Facts & Figures by Country
3.5.1 Europe Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Medical Soft Capsules Sales by Country (2018-2029)
3.5.3 Europe Medical Soft Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Soft Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Medical Soft Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Medical Soft Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Medical Soft Capsules Market Facts & Figures by Country
3.7.1 Latin America Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Medical Soft Capsules Sales by Country (2018-2029)
3.7.3 Latin America Medical Soft Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Soft Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Soft Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Medical Soft Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Medical Soft Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Medical Soft Capsules Sales by Type (2018-2029)
4.1.1 Global Medical Soft Capsules Sales by Type (2018-2023)
4.1.2 Global Medical Soft Capsules Sales by Type (2024-2029)
4.1.3 Global Medical Soft Capsules Sales Market Share by Type (2018-2029)
4.2 Global Medical Soft Capsules Revenue by Type (2018-2029)
4.2.1 Global Medical Soft Capsules Revenue by Type (2018-2023)
4.2.2 Global Medical Soft Capsules Revenue by Type (2024-2029)
4.2.3 Global Medical Soft Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Medical Soft Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Medical Soft Capsules Sales by Application (2018-2029)
5.1.1 Global Medical Soft Capsules Sales by Application (2018-2023)
5.1.2 Global Medical Soft Capsules Sales by Application (2024-2029)
5.1.3 Global Medical Soft Capsules Sales Market Share by Application (2018-2029)
5.2 Global Medical Soft Capsules Revenue by Application (2018-2029)
5.2.1 Global Medical Soft Capsules Revenue by Application (2018-2023)
5.2.2 Global Medical Soft Capsules Revenue by Application (2024-2029)
5.2.3 Global Medical Soft Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Medical Soft Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Medical Soft Capsules Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Aenova
6.2.1 Aenova Corporation Information
6.2.2 Aenova Description and Business Overview
6.2.3 Aenova Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Aenova Medical Soft Capsules Product Portfolio
6.2.5 Aenova Recent Developments/Updates
6.3 Catalent
6.3.1 Catalent Corporation Information
6.3.2 Catalent Description and Business Overview
6.3.3 Catalent Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Catalent Medical Soft Capsules Product Portfolio
6.3.5 Catalent Recent Developments/Updates
6.4 Boehringer Ingelheim
6.4.1 Boehringer Ingelheim Corporation Information
6.4.2 Boehringer Ingelheim Description and Business Overview
6.4.3 Boehringer Ingelheim Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boehringer Ingelheim Medical Soft Capsules Product Portfolio
6.4.5 Boehringer Ingelheim Recent Developments/Updates
6.5 Nature’s Bounty
6.5.1 Nature’s Bounty Corporation Information
6.5.2 Nature’s Bounty Description and Business Overview
6.5.3 Nature’s Bounty Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nature’s Bounty Medical Soft Capsules Product Portfolio
6.5.5 Nature’s Bounty Recent Developments/Updates
6.6 Patheon (Thermo Fisher Scientific)
6.6.1 Patheon (Thermo Fisher Scientific) Corporation Information
6.6.2 Patheon (Thermo Fisher Scientific) Description and Business Overview
6.6.3 Patheon (Thermo Fisher Scientific) Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Patheon (Thermo Fisher Scientific) Medical Soft Capsules Product Portfolio
6.6.5 Patheon (Thermo Fisher Scientific) Recent Developments/Updates
6.7 Procaps
6.6.1 Procaps Corporation Information
6.6.2 Procaps Description and Business Overview
6.6.3 Procaps Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Procaps Medical Soft Capsules Product Portfolio
6.7.5 Procaps Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Medical Soft Capsules Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Aland
6.9.1 Aland Corporation Information
6.9.2 Aland Description and Business Overview
6.9.3 Aland Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Aland Medical Soft Capsules Product Portfolio
6.9.5 Aland Recent Developments/Updates
6.10 Vertex
6.10.1 Vertex Corporation Information
6.10.2 Vertex Description and Business Overview
6.10.3 Vertex Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Vertex Medical Soft Capsules Product Portfolio
6.10.5 Vertex Recent Developments/Updates
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Medical Soft Capsules Description and Business Overview
6.11.3 Novartis Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Novartis Medical Soft Capsules Product Portfolio
6.11.5 Novartis Recent Developments/Updates
6.12 EuroCaps
6.12.1 EuroCaps Corporation Information
6.12.2 EuroCaps Medical Soft Capsules Description and Business Overview
6.12.3 EuroCaps Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 EuroCaps Medical Soft Capsules Product Portfolio
6.12.5 EuroCaps Recent Developments/Updates
6.13 Strides Pharma Science
6.13.1 Strides Pharma Science Corporation Information
6.13.2 Strides Pharma Science Medical Soft Capsules Description and Business Overview
6.13.3 Strides Pharma Science Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Strides Pharma Science Medical Soft Capsules Product Portfolio
6.13.5 Strides Pharma Science Recent Developments/Updates
6.14 Captek
6.14.1 Captek Corporation Information
6.14.2 Captek Medical Soft Capsules Description and Business Overview
6.14.3 Captek Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Captek Medical Soft Capsules Product Portfolio
6.14.5 Captek Recent Developments/Updates
6.15 Soft Gel Technologies
6.15.1 Soft Gel Technologies Corporation Information
6.15.2 Soft Gel Technologies Medical Soft Capsules Description and Business Overview
6.15.3 Soft Gel Technologies Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Soft Gel Technologies Medical Soft Capsules Product Portfolio
6.15.5 Soft Gel Technologies Recent Developments/Updates
6.16 NextPharma (from Lonza)
6.16.1 NextPharma (from Lonza) Corporation Information
6.16.2 NextPharma (from Lonza) Medical Soft Capsules Description and Business Overview
6.16.3 NextPharma (from Lonza) Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.16.4 NextPharma (from Lonza) Medical Soft Capsules Product Portfolio
6.16.5 NextPharma (from Lonza) Recent Developments/Updates
6.17 Roche
6.17.1 Roche Corporation Information
6.17.2 Roche Medical Soft Capsules Description and Business Overview
6.17.3 Roche Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Roche Medical Soft Capsules Product Portfolio
6.17.5 Roche Recent Developments/Updates
6.18 Amway
6.18.1 Amway Corporation Information
6.18.2 Amway Medical Soft Capsules Description and Business Overview
6.18.3 Amway Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Amway Medical Soft Capsules Product Portfolio
6.18.5 Amway Recent Developments/Updates
6.19 Sirio Pharma Co., Ltd
6.19.1 Sirio Pharma Co., Ltd Corporation Information
6.19.2 Sirio Pharma Co., Ltd Medical Soft Capsules Description and Business Overview
6.19.3 Sirio Pharma Co., Ltd Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Sirio Pharma Co., Ltd Medical Soft Capsules Product Portfolio
6.19.5 Sirio Pharma Co., Ltd Recent Developments/Updates
6.20 Weihai Baihe Biology Technological Co., Ltd
6.20.1 Weihai Baihe Biology Technological Co., Ltd Corporation Information
6.20.2 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Description and Business Overview
6.20.3 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Product Portfolio
6.20.5 Weihai Baihe Biology Technological Co., Ltd Recent Developments/Updates
6.21 Douglas
6.21.1 Douglas Corporation Information
6.21.2 Douglas Medical Soft Capsules Description and Business Overview
6.21.3 Douglas Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Douglas Medical Soft Capsules Product Portfolio
6.21.5 Douglas Recent Developments/Updates
6.22 Shineway Pharma
6.22.1 Shineway Pharma Corporation Information
6.22.2 Shineway Pharma Medical Soft Capsules Description and Business Overview
6.22.3 Shineway Pharma Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Shineway Pharma Medical Soft Capsules Product Portfolio
6.22.5 Shineway Pharma Recent Developments/Updates
6.23 Tsinghua Unigroup
6.23.1 Tsinghua Unigroup Corporation Information
6.23.2 Tsinghua Unigroup Medical Soft Capsules Description and Business Overview
6.23.3 Tsinghua Unigroup Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Tsinghua Unigroup Medical Soft Capsules Product Portfolio
6.23.5 Tsinghua Unigroup Recent Developments/Updates
6.24 Donghai Pharm
6.24.1 Donghai Pharm Corporation Information
6.24.2 Donghai Pharm Medical Soft Capsules Description and Business Overview
6.24.3 Donghai Pharm Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Donghai Pharm Medical Soft Capsules Product Portfolio
6.24.5 Donghai Pharm Recent Developments/Updates
6.25 Yi Chao
6.25.1 Yi Chao Corporation Information
6.25.2 Yi Chao Medical Soft Capsules Description and Business Overview
6.25.3 Yi Chao Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.25.4 Yi Chao Medical Soft Capsules Product Portfolio
6.25.5 Yi Chao Recent Developments/Updates
6.26 Yuwang Group
6.26.1 Yuwang Group Corporation Information
6.26.2 Yuwang Group Medical Soft Capsules Description and Business Overview
6.26.3 Yuwang Group Medical Soft Capsules Sales, Revenue and Gross Margin (2018-2023)
6.26.4 Yuwang Group Medical Soft Capsules Product Portfolio
6.26.5 Yuwang Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Soft Capsules Industry Chain Analysis
7.2 Medical Soft Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Soft Capsules Production Mode & Process
7.4 Medical Soft Capsules Sales and Marketing
7.4.1 Medical Soft Capsules Sales Channels
7.4.2 Medical Soft Capsules Distributors
7.5 Medical Soft Capsules Customers
8 Medical Soft Capsules Market Dynamics
8.1 Medical Soft Capsules Industry Trends
8.2 Medical Soft Capsules Market Drivers
8.3 Medical Soft Capsules Market Challenges
8.4 Medical Soft Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Medical Soft Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Medical Soft Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Medical Soft Capsules Market Competitive Situation by Manufacturers in 2022
Table 4. Global Medical Soft Capsules Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Medical Soft Capsules Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Medical Soft Capsules Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Medical Soft Capsules Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Medical Soft Capsules Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Medical Soft Capsules, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Medical Soft Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Medical Soft Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Medical Soft Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Medical Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Soft Capsules as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Medical Soft Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Medical Soft Capsules Sales by Region (2018-2023) & (Units)
Table 18. Global Medical Soft Capsules Sales Market Share by Region (2018-2023)
Table 19. Global Medical Soft Capsules Sales by Region (2024-2029) & (Units)
Table 20. Global Medical Soft Capsules Sales Market Share by Region (2024-2029)
Table 21. Global Medical Soft Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Medical Soft Capsules Revenue Market Share by Region (2018-2023)
Table 23. Global Medical Soft Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Medical Soft Capsules Revenue Market Share by Region (2024-2029)
Table 25. North America Medical Soft Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Medical Soft Capsules Sales by Country (2018-2023) & (Units)
Table 27. North America Medical Soft Capsules Sales by Country (2024-2029) & (Units)
Table 28. North America Medical Soft Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Medical Soft Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Medical Soft Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Medical Soft Capsules Sales by Country (2018-2023) & (Units)
Table 32. Europe Medical Soft Capsules Sales by Country (2024-2029) & (Units)
Table 33. Europe Medical Soft Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Medical Soft Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Medical Soft Capsules Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Medical Soft Capsules Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Medical Soft Capsules Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Medical Soft Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Medical Soft Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Medical Soft Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Medical Soft Capsules Sales by Country (2018-2023) & (Units)
Table 42. Latin America Medical Soft Capsules Sales by Country (2024-2029) & (Units)
Table 43. Latin America Medical Soft Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Medical Soft Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Medical Soft Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Medical Soft Capsules Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Medical Soft Capsules Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Medical Soft Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Medical Soft Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Medical Soft Capsules Sales (Units) by Type (2018-2023)
Table 51. Global Medical Soft Capsules Sales (Units) by Type (2024-2029)
Table 52. Global Medical Soft Capsules Sales Market Share by Type (2018-2023)
Table 53. Global Medical Soft Capsules Sales Market Share by Type (2024-2029)
Table 54. Global Medical Soft Capsules Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Medical Soft Capsules Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Medical Soft Capsules Revenue Market Share by Type (2018-2023)
Table 57. Global Medical Soft Capsules Revenue Market Share by Type (2024-2029)
Table 58. Global Medical Soft Capsules Price (US$/Unit) by Type (2018-2023)
Table 59. Global Medical Soft Capsules Price (US$/Unit) by Type (2024-2029)
Table 60. Global Medical Soft Capsules Sales (Units) by Application (2018-2023)
Table 61. Global Medical Soft Capsules Sales (Units) by Application (2024-2029)
Table 62. Global Medical Soft Capsules Sales Market Share by Application (2018-2023)
Table 63. Global Medical Soft Capsules Sales Market Share by Application (2024-2029)
Table 64. Global Medical Soft Capsules Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Medical Soft Capsules Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Medical Soft Capsules Revenue Market Share by Application (2018-2023)
Table 67. Global Medical Soft Capsules Revenue Market Share by Application (2024-2029)
Table 68. Global Medical Soft Capsules Price (US$/Unit) by Application (2018-2023)
Table 69. Global Medical Soft Capsules Price (US$/Unit) by Application (2024-2029)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. GSK Medical Soft Capsules Product
Table 74. GSK Recent Developments/Updates
Table 75. Aenova Corporation Information
Table 76. Aenova Description and Business Overview
Table 77. Aenova Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Aenova Medical Soft Capsules Product
Table 79. Aenova Recent Developments/Updates
Table 80. Catalent Corporation Information
Table 81. Catalent Description and Business Overview
Table 82. Catalent Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Catalent Medical Soft Capsules Product
Table 84. Catalent Recent Developments/Updates
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Boehringer Ingelheim Medical Soft Capsules Product
Table 89. Boehringer Ingelheim Recent Developments/Updates
Table 90. Nature’s Bounty Corporation Information
Table 91. Nature’s Bounty Description and Business Overview
Table 92. Nature’s Bounty Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Nature’s Bounty Medical Soft Capsules Product
Table 94. Nature’s Bounty Recent Developments/Updates
Table 95. Patheon (Thermo Fisher Scientific) Corporation Information
Table 96. Patheon (Thermo Fisher Scientific) Description and Business Overview
Table 97. Patheon (Thermo Fisher Scientific) Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Patheon (Thermo Fisher Scientific) Medical Soft Capsules Product
Table 99. Patheon (Thermo Fisher Scientific) Recent Developments/Updates
Table 100. Procaps Corporation Information
Table 101. Procaps Description and Business Overview
Table 102. Procaps Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Procaps Medical Soft Capsules Product
Table 104. Procaps Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. AstraZeneca Medical Soft Capsules Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Aland Corporation Information
Table 111. Aland Description and Business Overview
Table 112. Aland Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Aland Medical Soft Capsules Product
Table 114. Aland Recent Developments/Updates
Table 115. Vertex Corporation Information
Table 116. Vertex Description and Business Overview
Table 117. Vertex Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Vertex Medical Soft Capsules Product
Table 119. Vertex Recent Developments/Updates
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Novartis Medical Soft Capsules Product
Table 124. Novartis Recent Developments/Updates
Table 125. EuroCaps Corporation Information
Table 126. EuroCaps Description and Business Overview
Table 127. EuroCaps Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. EuroCaps Medical Soft Capsules Product
Table 129. EuroCaps Recent Developments/Updates
Table 130. Strides Pharma Science Corporation Information
Table 131. Strides Pharma Science Description and Business Overview
Table 132. Strides Pharma Science Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Strides Pharma Science Medical Soft Capsules Product
Table 134. Strides Pharma Science Recent Developments/Updates
Table 135. Captek Corporation Information
Table 136. Captek Description and Business Overview
Table 137. Captek Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Captek Medical Soft Capsules Product
Table 139. Captek Recent Developments/Updates
Table 140. Soft Gel Technologies Corporation Information
Table 141. Soft Gel Technologies Description and Business Overview
Table 142. Soft Gel Technologies Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Soft Gel Technologies Medical Soft Capsules Product
Table 144. Soft Gel Technologies Recent Developments/Updates
Table 145. NextPharma (from Lonza) Corporation Information
Table 146. NextPharma (from Lonza) Description and Business Overview
Table 147. NextPharma (from Lonza) Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. NextPharma (from Lonza) Medical Soft Capsules Product
Table 149. NextPharma (from Lonza) Recent Developments/Updates
Table 150. Roche Corporation Information
Table 151. Roche Description and Business Overview
Table 152. Roche Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Roche Medical Soft Capsules Product
Table 154. Roche Recent Developments/Updates
Table 155. Amway Corporation Information
Table 156. Amway Description and Business Overview
Table 157. Amway Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Amway Medical Soft Capsules Product
Table 159. Amway Recent Developments/Updates
Table 160. Sirio Pharma Co., Ltd Corporation Information
Table 161. Sirio Pharma Co., Ltd Description and Business Overview
Table 162. Sirio Pharma Co., Ltd Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Sirio Pharma Co., Ltd Medical Soft Capsules Product
Table 164. Sirio Pharma Co., Ltd Recent Developments/Updates
Table 165. Weihai Baihe Biology Technological Co., Ltd Corporation Information
Table 166. Weihai Baihe Biology Technological Co., Ltd Description and Business Overview
Table 167. Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Weihai Baihe Biology Technological Co., Ltd Medical Soft Capsules Product
Table 169. Weihai Baihe Biology Technological Co., Ltd Recent Developments/Updates
Table 170. Douglas Corporation Information
Table 171. Douglas Description and Business Overview
Table 172. Douglas Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. Douglas Medical Soft Capsules Product
Table 174. Douglas Recent Developments/Updates
Table 175. Shineway Pharma Corporation Information
Table 176. Shineway Pharma Description and Business Overview
Table 177. Shineway Pharma Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Shineway Pharma Medical Soft Capsules Product
Table 179. Shineway Pharma Recent Developments/Updates
Table 180. Tsinghua Unigroup Corporation Information
Table 181. Tsinghua Unigroup Description and Business Overview
Table 182. Tsinghua Unigroup Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 183. Tsinghua Unigroup Medical Soft Capsules Product
Table 184. Tsinghua Unigroup Recent Developments/Updates
Table 185. Donghai Pharm Corporation Information
Table 186. Donghai Pharm Description and Business Overview
Table 187. Donghai Pharm Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 188. Donghai Pharm Medical Soft Capsules Product
Table 189. Donghai Pharm Recent Developments/Updates
Table 190. Yi Chao Corporation Information
Table 191. Yi Chao Description and Business Overview
Table 192. Yi Chao Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 193. Yi Chao Medical Soft Capsules Product
Table 194. Yi Chao Recent Developments/Updates
Table 195. Yuwang Group Corporation Information
Table 196. Yuwang Group Description and Business Overview
Table 197. Yuwang Group Medical Soft Capsules Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 198. Yuwang Group Medical Soft Capsules Product
Table 199. Yuwang Group Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Medical Soft Capsules Distributors List
Table 203. Medical Soft Capsules Customers List
Table 204. Medical Soft Capsules Market Trends
Table 205. Medical Soft Capsules Market Drivers
Table 206. Medical Soft Capsules Market Challenges
Table 207. Medical Soft Capsules Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Medical Soft Capsules
Figure 2. Global Medical Soft Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Medical Soft Capsules Market Share by Type in 2022 & 2029
Figure 4. Gelatin Type Product Picture
Figure 5. Non-Animal Type Product Picture
Figure 6. Global Medical Soft Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Medical Soft Capsules Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Medical Institutions
Figure 11. Others
Figure 12. Global Medical Soft Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Medical Soft Capsules Market Size (2018-2029) & (US$ Million)
Figure 14. Global Medical Soft Capsules Sales (2018-2029) & (Units)
Figure 15. Global Medical Soft Capsules Average Price (US$/Unit) & (2018-2029)
Figure 16. Medical Soft Capsules Report Years Considered
Figure 17. Medical Soft Capsules Sales Share by Manufacturers in 2022
Figure 18. Global Medical Soft Capsules Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Medical Soft Capsules Players: Market Share by Revenue in 2022
Figure 20. Medical Soft Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Medical Soft Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Medical Soft Capsules Sales Market Share by Country (2018-2029)
Figure 23. North America Medical Soft Capsules Revenue Market Share by Country (2018-2029)
Figure 24. United States Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Medical Soft Capsules Sales Market Share by Country (2018-2029)
Figure 27. Europe Medical Soft Capsules Revenue Market Share by Country (2018-2029)
Figure 28. Germany Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Medical Soft Capsules Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Medical Soft Capsules Revenue Market Share by Region (2018-2029)
Figure 35. China Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Medical Soft Capsules Sales Market Share by Country (2018-2029)
Figure 45. Latin America Medical Soft Capsules Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Medical Soft Capsules Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Medical Soft Capsules Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Medical Soft Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Medical Soft Capsules by Type (2018-2029)
Figure 55. Global Revenue Market Share of Medical Soft Capsules by Type (2018-2029)
Figure 56. Global Medical Soft Capsules Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Medical Soft Capsules by Application (2018-2029)
Figure 58. Global Revenue Market Share of Medical Soft Capsules by Application (2018-2029)
Figure 59. Global Medical Soft Capsules Price (US$/Unit) by Application (2018-2029)
Figure 60. Medical Soft Capsules Value Chain
Figure 61. Medical Soft Capsules Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • オセルタミビルリン酸塩カプセルの世界市場2023年：30mg、45mg、75mg
  • クレアチンカプセルの世界市場2023年：濃縮、通常
  • イブプロフェンカプセルの世界市場2023年：200mg/個、300mg/個
  • ジクロフェナクナトリウム徐放性カプセルの世界市場2023年：仕様0.25g、仕様0.5g
  • オメプラゾール腸溶性カプセルの世界市場2023年：10mg/本、20mg/本
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8813 )"医療用ソフトカプセルの世界市場2023年：ゼラチンタイプ、ノンアニマルタイプ" (英文：Global Medical Soft Capsules Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。